Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Antonelli

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Lancet (London, England)|January 17, 2004
Neutralising antibodies against interferon beta in multiple sclerosisGuido Antonelli
The New Microbiologica|October 11, 2008
Biological basis for a proper clinical application of alpha interferonsGuido Antonelli
Viruses|November 14, 2019
HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative ReviewGiuseppe Gentile, Guido Antonelli
International Journal of Antimicrobial Agents|June 26, 2012
Antiviral therapy: old and current issuesGuido Antonelli, Ombretta Turriziani
Cytokine & Growth Factor Reviews|March 27, 2018
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiomeCarolina Scagnolari, Guido Antonelli
Expert Opinion on Biological Therapy|January 29, 2013
Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis CCarolina Scagnolari, Guido Antonelli
Expert Opinion on Biological Therapy|July 22, 2006
Neutralising antibodies to IFN-beta in patients with multiple sclerosisFrancesca Bagnato, Marco Riva, Guido Antonelli
Minerva Pediatrica|October 19, 2018
Respiratory syncytial virusAlessandra Pierangeli, Carolina Scagnolari, Guido Antonelli
The New Microbiologica|October 26, 2005
Considerations on the development of serum antibodies to interferon-betaGuido Antonelli, Francesca Bagnato, Ferdinando Dianzani
The New Microbiologica|March 11, 2016
Ebolavirus and evidence-based speculationsDaniele Focosi, Guido Antonelli, Fabrizio Maggi
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Lancet (London, England)|January 17, 2004
Neutralising antibodies against interferon beta in multiple sclerosisGuido Antonelli
The New Microbiologica|October 11, 2008
Biological basis for a proper clinical application of alpha interferonsGuido Antonelli
Viruses|November 14, 2019
HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative ReviewGiuseppe Gentile, Guido Antonelli
International Journal of Antimicrobial Agents|June 26, 2012
Antiviral therapy: old and current issuesGuido Antonelli, Ombretta Turriziani
Cytokine & Growth Factor Reviews|March 27, 2018
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiomeCarolina Scagnolari, Guido Antonelli
Expert Opinion on Biological Therapy|January 29, 2013
Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis CCarolina Scagnolari, Guido Antonelli
Expert Opinion on Biological Therapy|July 22, 2006
Neutralising antibodies to IFN-beta in patients with multiple sclerosisFrancesca Bagnato, Marco Riva, Guido Antonelli
Minerva Pediatrica|October 19, 2018
Respiratory syncytial virusAlessandra Pierangeli, Carolina Scagnolari, Guido Antonelli
The New Microbiologica|October 26, 2005
Considerations on the development of serum antibodies to interferon-betaGuido Antonelli, Francesca Bagnato, Ferdinando Dianzani
The New Microbiologica|March 11, 2016
Ebolavirus and evidence-based speculationsDaniele Focosi, Guido Antonelli, Fabrizio Maggi
Pageof 26